Showing results (51-60 of 482) with videos related to
Sort By:
Pageof 49
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2019
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancerMatteo Morotti, Esther Bridges, Alessandro Valli, et al.Surgical Oncology|May 29, 2002
Angiogenesis in bladder cancer--prognostic marker and target for future therapyEdward H Streeter, Adrian L HarrisAPMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 26, 2004
Histological quantitation of tumour angiogenesisStephen B Fox, Adrian L HarrisJournal of Mammary Gland Biology and Neoplasia|August 23, 2006
The role of copper in tumour angiogenesisSarah A Lowndes, Adrian L HarrisMolecular Cancer Therapeutics|September 21, 2006
Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA bindingDylan T Jones, Adrian L HarrisBiochemical Pharmacology|March 9, 2011
The angiogenic process as a therapeutic target in cancerEsther M Bridges, Adrian L HarrisClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2013
Microenvironmental induced essentiality of autophagyDean C Singleton, Adrian L HarrisExpert Opinion on Therapeutic Targets|April 20, 2012
Small-molecule inhibitors of the HIF pathway and synthetic lethal interactionsDylan T Jones, Adrian L HarrisCancer Cell|June 15, 2007
The potential of new tumor endothelium-specific markers for the development of antivascular therapyJi-Liang Li, Adrian L HarrisFrontiers in Bioscience (Landmark Edition)|March 11, 2009
Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implicationsJi-Liang Li, Adrian L HarrisPageof 49